1 擎華控股集團有限公司 香港聯合交易所有限公司（「聯交所」）GEM之特色 GEM之定位，乃為較於聯交所上市之其他公司帶有更高投資風險之中小型公司提供一個上 市之市場。有意投資之人士應了解投資於該等公司之潛在風險，並應經過審慎周詳之考慮 後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於主板買賣之證券承受 較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及香港聯合交易所有限公司對本報告之內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示概不就因本報告全部或任何部分內容產生或 因倚賴該等內容引致之任何損失承擔任何責任。 本報告乃遵照香港聯合交易所有限公司GEM證券上市規則之規定提供有關擎華控股集團有 限公司之資料。擎華控股集團有限公司各董事願就本報告共同及個別承擔全部責任，並經作 出一切合理查詢後確認，就彼等所深知及確信，本報告所載之資料在各重大方面均屬準確及 完整，且無誤導或欺詐成份；及本報告並無遺漏其他事實致使本報告所載任何陳述產生誤 導。 二零二五年中期報告 2 公司資料 執行董事 唐才智先生 （主席） 鍾楚霖先 ...

思路迪医药股份有限公司 2025 INTERIM REPORT 中期報告 Contents 目錄 | 2 | Definitions | 釋義 | | --- | --- | --- | | 7 | Corporate Information | 公司資料 | | 10 | Business Highlights | 業務摘要 | | 14 | Financial Summary | 財務概要 | | 18 | Management Discussion and Analysis | 管理層討論及分析 | | 52 | Other Information | 其他資料 | | 71 | Independent Review Report | 獨立審閱報告 | | 73 | Interim Condensed Consolidated Statement of Profit or Loss and | 中期簡明綜合損益及 | | | Other Comprehensive Income | 其他全面收益表 | | 74 | Interim Condensed Consolidated Statement of ...

R W A 2025 INTERIM REPORT 中期報告 Web 3.0 Since its establishment in 2005, the Group has been deeply involved in the R&D of recommendation technology and continuously optimized its proprietary intelligent recommendation engine, Easou Recommendation Engine. The Group is primarily engaged in the artificial intelligence (AI) application sector, which includes online reading platform services, digital marketing services, online games publishing services and other digital content services. In addition, the Group is ...

Contents目錄 | Corporate Information 公司資料 | 3 | | --- | --- | | Management Discussion and Outlook 管理層討論及展望 | 5 | | Condensed Consolidated Statement of Profit or Loss 簡明綜合損益表 | 17 | | Condensed Consolidated Statement of Other Comprehensive Income | 19 | | 簡明綜合其他全面收益表 | | | Condensed Consolidated Statement of Financial Position 簡明綜合財務狀況表 | 20 | | Condensed Consolidated Statement of Changes in Equity 簡明綜合權益變動表 | 22 | | Condensed Consolidated Statement of Cash Flows 簡明綜合現金流量表 | 24 | | Notes to the Condensed Conso ...

| 2 | 公司資料 | | --- | --- | | 4 | 管理層討論與分析 | | 16 | 企業管治及其他資料 | | 24 | 簡明綜合財務報表審閱報告 | | 25 | 簡明綜合損益及其他全面收益表 | | 26 | 簡明綜合財務狀況表 | | 28 | 簡明綜合權益變動表 | | 29 | 簡明綜合現金流量表 | | 31 | 簡明綜合財務報表附註 | | 62 | 釋義 | 公司資料 董事會 深圳市天圖投資管理股份有限公司 TIAN TU CAPITAL CO., LTD. （於中華人民共和國註冊成立的股份有限公司） 股份代號 : 1973 2025 中 期 報 告 目錄 刁揚先生 （主席，自2025年5月23日起生效） 王永華先生 王世林先生 （辭任主席，自2025年5月23日起生效） 執行董事 王永華先生 （董事長） 馮衛東先生 鄒雲麗女士 李小毅先生 （於2025年5月23日辭任） 非執行董事 王仕生先生 （於2025年5月23日獲委任） 黎瀾先生 姚嘉雯女士 獨立非執行董事 王世林先生 刁揚先生 蔡洌先生 審計委員會 蔡洌先生 （主席） 姚嘉雯女士 刁揚先生 薪酬委員會 提名委員會 ...

Financial Performance - For the six months ended June 30, 2025, the company reported revenue of RMB 12,935,000, a significant decrease of 91.8% compared to RMB 157,288,000 for the same period in 2024[9]. - The gross profit for the same period was RMB 3,655,000, down from RMB 12,184,000, indicating a decline in profitability[9]. - The company recorded a net loss of RMB 3,564,000 for the six months ended June 30, 2025, compared to a net loss of RMB 16,353,000 in the prior year, showing an improvement in loss[10]. - Total revenue for the six months ended June 30, 2025, was RMB 12,935,000, a decrease of 18.5% compared to RMB 15,857,000 for the same period in 2024[22]. - Net loss for the six months ended June 30, 2025, was RMB 3,564,000, compared to a net loss of RMB 16,353,000 for the same period in 2024, indicating an improvement[22]. - The company reported a total comprehensive loss of RMB 1,805,000 for the six months ended June 30, 2025, compared to a total comprehensive loss of RMB 12,842,000 for the same period in 2024[11]. - The company reported a total comprehensive loss attributable to owners of approximately RMB 1.8 million for the six months ended June 30, 2025, down from RMB 12.8 million for the same period in 2024[56]. Assets and Liabilities - Total assets as of June 30, 2025, were RMB 1,034,999,000, slightly up from RMB 1,015,981,000 at the end of 2024[8]. - The company's total equity decreased to RMB 544,038,000 from RMB 545,843,000 at the end of 2024, reflecting a marginal decline[7]. - The company’s financial liabilities increased to RMB 490,961,000 from RMB 470,138,000, indicating a rise in debt levels[8]. - As of June 30, 2025, the total borrowings of the group amounted to approximately RMB 374.3 million, an increase from RMB 267.1 million as of December 31, 2024[76]. - The debt-to-equity ratio as of June 30, 2025, was approximately 40.8%, up from 32.9% as of December 31, 2024[77]. - The current ratio decreased to approximately 0.87 times as of June 30, 2025, compared to 1.07 times as of December 31, 2024[77]. Cash Flow - The net cash used in operating activities for the six months ended June 30, 2025, is RMB 24,083,000, compared to RMB 25,013,000 for the same period in 2024, indicating a slight improvement[12]. - The net cash used in investing activities for the six months ended June 30, 2025, is RMB 92,611,000, an increase from RMB 79,774,000 in 2024[12]. - The net cash generated from financing activities for the six months ended June 30, 2025, is RMB 106,614,000, significantly higher than RMB 32,644,000 in the previous year[12]. - The company reported a cash and cash equivalents balance of RMB 69,912,000 as of June 30, 2025, a decrease of 12.9% from RMB 80,001,000 as of December 31, 2024[33]. - The group's cash and bank balances were approximately RMB 72.4 million as of June 30, 2025, down from RMB 80.0 million as of December 31, 2024[76]. Operational Highlights - The company’s operations are primarily focused on iron ore processing and the sale of iron concentrates and other minerals in China[13]. - The company processed 103,000 tons of Brazilian coarse powder in the first half of 2025, continuing its processing business[57]. - The sales revenue from coal and coal products trade reached RMB 6.171 million in the first half of 2025, leveraging logistics advantages[57]. - The company aims to increase coal and coal product trading volume by leveraging logistics advantages and existing customer relationships[73]. - The company intends to enhance production capacity at the Zhuge Shangyu processing plant in the second half of 2025, striving for better output compared to the first half[74]. Expenses and Costs - The company’s administrative expenses rose to RMB 29,811,000 from RMB 28,489,000, indicating increased operational costs[9]. - Distribution costs and administrative expenses decreased by approximately RMB 1.8 million or 5.7% to about RMB 29.8 million for the six months ended June 30, 2025[70]. - Employee benefits expenses for the six months ended June 30, 2025, were approximately RMB 7.4 million, compared to RMB 6.8 million for the same period in 2024[81]. - The total sales cost for the six months ended June 30, 2025, decreased by approximately 93.6% to about RMB 9.3 million, down from approximately RMB 145.1 million in the previous year[67]. Investments and Future Plans - The investment in the Zhugeshangyu mining and selection plant construction is approximately RMB 1.5 billion, focusing on mining, production line construction, and automation[57]. - The company plans to invest approximately RMB 1.5 billion in the construction of the Zhuge Shangyu mine and processing plant, focusing on mining operations and production line construction[73]. - The company is actively pursuing low-carbon and environmentally friendly projects, with ongoing ecological enhancement works expected to be completed by the end of the year[58]. - The group plans to focus on low-carbon and sustainable growth projects in the second half of the year[78]. Governance and Compliance - The company has adopted the corporate governance code as its own governance code and believes it has complied with all relevant provisions during the six-month period ending June 30, 2025[98]. - The audit committee, consisting of four independent non-executive directors, reviewed the unaudited interim consolidated results for the six months ending June 30, 2025, ensuring compliance with applicable accounting standards and regulations[99].

IVD MEDICAL HOLDING LIMITED 華 檢 醫 療 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） 股份代號：1931 中期報告 2025 IVD MEDICAL HOLDING LIMITED 華 檢 醫 療 控 股 有 限 公 司 Stock Code: 1931 (Incorporated in the Cayman Islands with limited liability) Interim Report 2025 | 公司資料 | 2 | | --- | --- | | 財務摘要 | 4 | | 管理層討論及分析 | 6 | | 中期簡明綜合損益及其他全面收益表 | 30 | | 中期簡明綜合財務狀況表 | 32 | | 中期簡明綜合權益變動表 | 34 | | 中期簡明綜合現金流量表 | 36 | | 中期簡明綜合財務資料附註 | 38 | | 其他資料 | 57 | 公司資料 董事 執行董事 2025 Interim Report 中期報告 IVD MEDICAL HOLDING LIMI TED 華檢醫療控股有限公司 目錄 何鞠誠先生 （自二零二五年七月一日辭任 ...

Stock Code 股份代號 : 1683 (Incorporated in the Cayman Islands with limited liability 於開曼群島註冊成立的有限公司) Contents 目 錄 | Corporate Information | 02 | | --- | --- | | 公司資料 | | | Chairman's Statement | 04 | | 主席報告 | | | Management Discussion and Analysis | 06 | | 管理層討論與分析 | | | Condensed Consolidated Statement of | | | Profit or Loss | 10 | | 簡明綜合損益表 | | | Condensed Consolidated Statement of | | | Comprehensive Income | 11 | | 簡明綜合全面收益表 | | | Condensed Consolidated Statement of | | | Financial Position | 12 | | 簡明綜合財 ...

康方生物科技(開曼)有限公司 Akeso, Inc. (於開曼群島註冊成立的有限公司) (Incorporated in the Cayman Islands with limited liability) Stock Code 股份代號 : 9926 2025 中期報告 INTERIM REPORT 康方生物科技(開曼)有限公司 Akeso, Inc. INTERIM REPORT 2025 中期報告 目 錄 | | 頁次 | | --- | --- | | 公司簡介 | 2 | | 釋義 | 3 | | 公司資料 | 6 | | 摘要 | 8 | | 管理層討論及分析 | 9 | | 補充資料 | 27 | | 獨立審閱報告 | 66 | | 中期簡明綜合損益及其他全面收益表 | 67 | | 中期簡明綜合財務狀況表 | 69 | | 中期簡明綜合權益變動表 | 71 | | 中期簡明綜合現金流量表 | 73 | | 中期簡明綜合財務資料附註 | 75 | 公司簡介 康方生物科技（開曼）有限公司是一家致力於研究、開發、生產及商業化讓全球病人可負擔的創新抗體藥的生物製藥 公司。自成立以來，本公司建立了端對端 ...

Company Information This section details the company's corporate structure, including Board and committee changes, key personnel, and essential corporate information [Board of Directors](index=3&type=section&id=Board%20of%20Directors) The Board of Directors underwent significant changes, with new CEO and Executive Director appointments, and multiple resignations or suspensions - Mr. Qiu Yiming was appointed Chief Executive Officer on **May 2, 2025**[4](index=4&type=chunk) - Ms. Chen Jianyue was appointed Executive Director on **March 12, 2025**[4](index=4&type=chunk) - Mr. Guan Xiongjun was appointed Executive Director on **May 2, 2025**[4](index=4&type=chunk) - Mr. Au Chi Fung resigned as Executive Director on **July 16, 2025**[4](index=4&type=chunk) - Ms. Bohra Shilpa Rajesh resigned as Executive Director on **March 12, 2025**[4](index=4&type=chunk) - Dr. Zhao Zhihua resigned as Executive Director on **May 2, 2025**[4](index=4&type=chunk) - Mr. Luk Man Fu resigned as Executive Director on **April 2, 2025**[4](index=4&type=chunk) - The executive directorships of Mr. Li Kam Hung and Mr. Yu Ming Hao were suspended[4](index=4&type=chunk) - Ms. Dong Qing, Mr. Tam Tsz Hin, and Mr. Yu Kwan Sheung were appointed Independent Non-executive Directors during the reporting period[4](index=4&type=chunk) [Committees](index=3&type=section&id=Committees) Changes occurred in the chairpersons and members of the Audit, Remuneration, and Nomination Committees, reflecting the Board restructuring - Mr. Yu Kwan Sheung was appointed Chairman of the Audit Committee on **July 16, 2025**[4](index=4&type=chunk) - Mr. Tam Tsz Hin was appointed Chairman of the Remuneration Committee on **July 16, 2025**[5](index=5&type=chunk) - Ms. Dong Qing was appointed Chairman of the Nomination Committee on **July 16, 2025**[5](index=5&type=chunk) [Authorized Representatives and Company Secretary](index=4&type=section&id=Authorized%20Representatives%20and%20Company%20Secretary) Mr. Au Chi Fung resigned as Authorized Representative, with Mr. Guan Xiongjun appointed, while Mr. Wong Sze Lok remains Company Secretary - Mr. Au Chi Fung resigned as Authorized Representative on **July 16, 2025**[6](index=6&type=chunk) - Mr. Guan Xiongjun was appointed Authorized Representative on **July 16, 2025**[6](index=6&type=chunk) - Mr. Wong Sze Lok serves as Company Secretary[6](index=6&type=chunk) [Auditor and Registered Office](index=4&type=section&id=Auditor%20and%20Registered%20Office) The company's auditor is HLB Hodgson Impey Cheng Limited, and its registered office is located in the Cayman Islands - The auditor is HLB Hodgson Impey Cheng Limited[6](index=6&type=chunk) - The registered office is located at Cricket Square, Cayman Islands[6](index=6&type=chunk) [Principal Place of Business and Share Registrar](index=4&type=section&id=Principal%20Place%20of%20Business%20and%20Share%20Registrar) The company maintains principal places of business in Macau and Hong Kong, with its principal share registrar in the Cayman Islands and Hong Kong branch registrar being Tricor Investor Services Limited - The Macau head office and principal place of business is located at Alameda Dr. Carlos d'Assumpcao[6](index=6&type=chunk) - The Hong Kong principal place of business is located at On Lok Industrial Centre, Chai Wan, Hong Kong[6](index=6&type=chunk) - The Hong Kong branch share registrar is Tricor Investor Services Limited[7](index=7&type=chunk) [Principal Bankers and Legal Advisers](index=4&type=section&id=Principal%20Bankers%20and%20Legal%20Advisers) The company's principal bankers include Banco Comercial de Macau and Banco Weng Hang, with Khoo & Co as its Hong Kong legal adviser - Principal bankers are Banco Comercial de Macau and Banco Weng Hang[7](index=7&type=chunk) - Hong Kong legal adviser is Khoo & Co[7](index=7&type=chunk) [Stock Code and Website](index=4&type=section&id=Stock%20Code%20and%20Website) The company's stock code is 3321, listed on the Main Board of The Stock Exchange of Hong Kong Limited, with its website at whh.com.hk - The stock code is **3321**, listed on the Main Board of The Stock Exchange of Hong Kong Limited[7](index=7&type=chunk) - The company's website is whh.com.hk[7](index=7&type=chunk) Management Discussion and Analysis This section provides an overview of the Group's business operations, financial performance, capital structure, and risk management strategies [Business Review and Prospects](index=5&type=section&id=Business%20Review%20and%20Prospects) The Group primarily offers renovation and maintenance services in Macau and Hong Kong, focusing on commercial properties, but faced challenges in new project acquisition due to senior management issues, leading to a strategic shift towards anti-counterfeiting technology and related interior decoration projects - The Group primarily engages in providing renovation, maintenance, and repair services in Macau and Hong Kong, historically focused on commercial properties, particularly within integrated resorts in Macau[10](index=10&type=chunk) - During the reporting period, the Group's performance was significantly impacted by events involving senior management, leading to challenges in securing new casino projects and a notable decrease in new project acquisitions[10](index=10&type=chunk) - On **May 13, 2025**, the Company entered into a non-legally binding Memorandum of Understanding with Nanjing Zhongke Micropoint Group Co, Ltd to explore business opportunities in developing and distributing cutting-edge anti-counterfeiting technology products[10](index=10&type=chunk) - The Company will directly participate as a consultant or engage in interior decoration projects for multiple independent data and production centers to be established in dozens of provinces across China for the Nanjing Zhongke Micropoint project[10](index=10&type=chunk) - The Board proposes to change the company's English name to "Zhongke Micropoint (Group) Co., Ltd" and adopt the Chinese name "中科微點（集團）有限公司" to reflect the new business direction[11](index=11&type=chunk) [Financial Review](index=6&type=section&id=Financial%20Review) For the six months ended June 30, 2025, the Group's total revenue significantly decreased by **82.9%** to **MOP1.1 million**, with a loss for the period of approximately **MOP58.0 million**, largely consistent with the prior year, primarily due to reduced new project acquisitions, increased impairment losses, and higher finance costs Major Financial Data Overview | Indicator | Six Months Ended June 30, 2025 (thousand MOP) | Six Months Ended June 30, 2024 (thousand MOP) | | :--- | :--- | :--- | | Total Revenue | 1,100 | 6,100 | | Loss for the Period | (58,000) | (58,600) | - The Group completed **1** renovation project in Macau during the six months ended **June 30, 2025**[13](index=13&type=chunk) Revenue Change | Indicator | Six Months Ended June 30, 2025 (thousand MOP) | Six Months Ended June 30, 2024 (thousand MOP) | Change (thousand MOP) | Change Rate | | :--- | :--- | :--- | :--- | :--- | | Revenue | 1,100 | 6,100 | (5,000) | -82.9% | Direct Costs Change | Indicator | Six Months Ended June 30, 2025 (thousand MOP) | Six Months Ended June 30, 2024 (thousand MOP) | Change (thousand MOP) | Change Rate | | :--- | :--- | :--- | :--- | :--- | | Total Direct Costs | 1,000 | 5,900 | (4,900) | -83.0% | Gross Profit and Gross Margin Change | Indicator | Six Months Ended June 30, 2025 (thousand MOP) | Six Months Ended June 30, 2024 (thousand MOP) | | :--- | :--- | :--- | | Gross Profit | 100 | 200 | | Gross Margin | 3.6% | 2.9% | Other Income and Net Other Gains Change | Indicator | Six Months Ended June 30, 2025 (thousand MOP) | Six Months Ended June 30, 2024 (thousand MOP) | Change (thousand MOP) | Change Rate | | :--- | :--- | :--- | :--- | :--- | | Other Income and Net Other Gains | 0 | 1 | (1) | -100% | - Other income and net other gains primarily comprised bank interest income[18](index=18&type=chunk) Impairment Losses Change | Indicator | Six Months Ended June 30, 2025 (thousand MOP) | Six Months Ended June 30, 2024 (thousand MOP) | Change (thousand MOP) | | :--- | :--- | :--- | :--- | | Provision for impairment losses on financial assets and contract assets | 49,000 | 42,800 | 6,200 | - The increase in impairment losses was due to a decrease in the recoverability of long outstanding trade receivables during the reporting period[19](index=19&type=chunk) Administrative Expenses Change | Indicator | Six Months Ended June 30, 2025 (thousand MOP) | Six Months Ended June 30, 2024 (thousand MOP) | Change (thousand MOP) | | :--- | :--- | :--- | :--- | | Administrative Expenses | 5,400 | 14,400 | (9,000) | | Percentage of Total Revenue | 515.5% | 235.4% | | | Administrative Staff Costs | 4,000 | 8,200 | (4,200) | - The